A prospective investigation of pain and fatigue following pelvic exenteration.


Journal

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
ISSN: 1532-2157
Titre abrégé: Eur J Surg Oncol
Pays: England
ID NLM: 8504356

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 18 02 2021
revised: 01 07 2021
accepted: 25 07 2021
pubmed: 10 8 2021
medline: 17 2 2022
entrez: 9 8 2021
Statut: ppublish

Résumé

To describe the long-term course of pain and fatigue in patients undergoing pelvic exenteration and to evaluate potential prognostic factors for these outcomes. Prospective cohort study. Royal Prince Alfred Hospital, Sydney, Australia. Consecutive patients undergoing pelvic exenteration surgery between July 2008 and December 2017. Pain and fatigue scores collected via SF-36v2 Health surveys pre-operatively and at eight time-points post-operatively for a period of 5-years. The course of pain and fatigue were described according to the following prognostic factors; bone resection (yes/no), cancer type (primary/recurrent), margin status (R0/R1-2) and extent of exenteration (complete/partial). 345 of 459 eligible patients (75 %) consented to the study. The course of pain and fatigue over the 5 year follow-up was favourable. Patients undergoing pelvic exenteration with an R0 resection margin or without bone resection presented lower pain levels throughout the follow-up period. Bone resection, positive surgical margin (R1/R2) and type of cancer did not influence fatigue trajectories. Patients undergoing complete pelvic exenteration were more likely to report a higher level of pain and fatigue in the initial follow-up period, however this difference was not observed in the longer-term. Patients undergoing PE (Austin and Solomon, 2015) [1] can expect improvement but an incomplete recovery in the levels of pain and fatigue postoperatively over the 5-year follow-up period. Bone resection as part of exenteration demonstrated higher levels of pain and fatigue.

Identifiants

pubmed: 34366173
pii: S0748-7983(21)00643-0
doi: 10.1016/j.ejso.2021.07.022
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3137-3143

Informations de copyright

Copyright © 2021 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Kenneth Vuong (K)

Surgical Outcomes Research Centre (SOuRCe), University of Sydney & Sydney Local Health District, New South Wales, Australia; Data Analysis Surgical Outcomes Unit (DASO), Royal North Shore Hospital, Sydney, New South Wales, Australia. Electronic address: kenneth.vuong@health.nsw.gov.au.

Lyndal M Alchin (LM)

Surgical Outcomes Research Centre (SOuRCe), University of Sydney & Sydney Local Health District, New South Wales, Australia.

Michael J Solomon (MJ)

Surgical Outcomes Research Centre (SOuRCe), University of Sydney & Sydney Local Health District, New South Wales, Australia; The University of Sydney, Faculty of Medicine and Health, Central Clinical School, Sydney, New South Wales, Australia; The Institute of Academic Surgery at RPA, Sydney Local Health District, Sydney, New South Wales, Australia; Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

Cherry E Koh (CE)

Surgical Outcomes Research Centre (SOuRCe), University of Sydney & Sydney Local Health District, New South Wales, Australia; The Institute of Academic Surgery at RPA, Sydney Local Health District, Sydney, New South Wales, Australia; Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

Daniel Steffens (D)

Surgical Outcomes Research Centre (SOuRCe), University of Sydney & Sydney Local Health District, New South Wales, Australia; The University of Sydney, Faculty of Medicine and Health, Central Clinical School, Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH